S. Higasa

发表

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan

J. Takamatsu, M. Taneichi, A. Shirahata, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Quality of life of people living with HIV compared with that of the general population in Japan.

S. Higasa, Shinichi Hikasa, Shota Shimabukuro, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus.

M. Namba, S. Higasa, E. Kakishita, 2002, Thrombosis research.

The prevalence of neutralizing antibodies against adeno‐associated virus capsids is reduced in young Japanese individuals

T. Ohmori, S. Madoiwa, J. Mimuro, 2014, Journal of medical virology.

Abacavir/lamivudine versus tenofovir/emtricitabine with atazanavir/ritonavir for treatment-naive Japanese patients with HIV-1 infection: a randomized multicenter trial.

S. Matsushita, H. Mitsuya, S. Oka, 2013, Internal medicine.

Utility of estimated glomerular filtration rate based on cystatin C in patients receiving combination antiretroviral therapy including dolutegravir

S. Higasa, Shinichi Hikasa, Shota Shimabukuro, 2018, Infectious diseases.

Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia

M. Nojima, T. Matsushita, K. Amano, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study

S. Higasa, Shinichi Hikasa, Shota Shimabukuro, 2019, Journal of Pharmaceutical Health Care and Sciences.

Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan

Y. Miyakawa, T. Miyata, K. Kokame, 2017, International Journal of Hematology.

Serum macrophage colony‐stimulating factor (M‐CSF) level is elevated in patients with old cerebral infarction related to vascular damage

H. Yoshimoto, H. Tsujioka, S. Higasa, 1999, American journal of hematology.

Severe acute heart failure during or following cytokine release syndrome after CAR T-cell therapy

M. Asakura, H. Tamaki, M. Ishihara, 2022, Leukemia research reports.

Comparison between the impact of tenofovir alafenamide and that of abacavir on rapid kidney function decline: A retrospective observational study

S. Higasa, Shinichi Hikasa, Shota Shimabukuro, 2022, HIV medicine.

Clinical pharmacological study of a plasma‐derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors – Phase I trial

Y. Ohashi, J. Takamatsu, A. Shirahata, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical practice guidelines for the diagnosis and management of patients with acquired hemophilia A approved by The Japanese Society on Thrombosis and Hemostasis

Y. Toyama, J. Mimuro, J. Takamatsu, 2011 .

Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10‐year Japanese postmarketing surveillance data

K. Amano, M. Shima, S. Higasa, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

A Phase II clinical trial of a mixture of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics

Y. Ohashi, J. Takamatsu, H. Mugishima, 2013, Haemophilia.

Results of clot waveform analysis and thrombin generation test for a plasma‐derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd report

Y. Ohashi, J. Takamatsu, A. Shirahata, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Enhancing effect of platelets on staphylokinase-mediated clot lysis and plasminogen activation.

H. Yoshimoto, H. Tsujioka, S. Higasa, 1995, Thrombosis research.

Effect of Plasminogen Activator on Platelet Aggregation

S. Higasa, Y. Nishida, E. Kakishita, 1993 .

Effects of Bisphosphonate Administration on the Bone Mass in Immune Thrombocytopenic Purpura Patients Under Treatment With Steroids

T. Takubo, Y. Tomiyama, K. Saigo, 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia

H. Tamaki, K. Yamahara, S. Higasa, 2021, Transfusion medicine.

Pregnancy‐induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw–Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients

J. George, T. Miyata, K. Kokame, 2009, British journal of haematology.

Combination effect of eicosapentaenoic acid and platelet suppressive agents on platelets

S. Higasa, E. Kakishita, A. Suehiro, 1994 .

A 3-year consecutive survey on current status of acquired inhibitors against coagulation factors in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2008 .

Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations

B. Konkle, Tetsuji Sato, T. Matsushita, 2017, International Journal of Hematology.

A multi-center survey of hospital charges for hemophilia and the related diseases in Japan

K. Amano, M. Shima, S. Higasa, 2006 .

Sub analysis of Japanese patients with hemophilia B in rIX-FP clinical trial

Koji Yamamoto, T. Matsushita, K. Nogami, 2017 .

A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors

Y. Ohashi, J. Takamatsu, H. Mugishima, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical conditions and risk factors for inhibitor‐development in patients with haemophilia: A decade‐long prospective cohort study in Japan, J‐HIS2 (Japan Hemophilia Inhibitor Study 2)

J. Takamatsu, S. Ohga, Masao Kobayashi, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Suitability of four polymorphic DNA markers for indirect genetic diagnosis of haemophilia A in Japanese subject.

S. Higasa, E. Kakishita, A. Sawada, 2002, Thrombosis research.

Decreased levels of urinary liver-type fatty acid-binding protein after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study

S. Higasa, Shinichi Hikasa, Shota Shimabukuro, 2019, International journal of STD & AIDS.

In vitro inhibitory effect of sarpogrelate hydrochloride on serotonin-induced platelet small-aggregate formation

H. Yoshimoto, S. Higasa, M. Marumo, 2000 .

Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients

S. Higasa, T. Shirasaka, H. Sano, 2005, AIDS.

Difference of Progression to AIDS According to CD4 Cell Count, Plasma HIV RNA Level and the Use of Antiretroviral Therapy among HIV Patients Infected through Blood Products in Japan

S. Oka, Takuhiro Yamaguchi, M. Kawado, 2006, Journal of epidemiology.

Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura

T. Miyata, K. Hatakeyama, K. Kokame, 2020, Journal of thrombosis and haemostasis : JTH.

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs

M. Hayakawa, S. Ishikawa, T. Ohmori, 2022, medRxiv.

Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation

T. Kijima, H. Tamaki, H. Ogawa, 2022, International Journal of Hematology.

Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation

S. Higasa, H. Takatsuka, E. Kakishita, 2002, Bone Marrow Transplantation.

High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy

S. Hirota, S. Higasa, M. Okada, 2021, HemaSphere.

Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study

S. Higasa, Shinichi Hikasa, Shota Shimabukuro, 2018, International journal of STD & AIDS.

The association between urinary liver-type fatty acid-binding protein and chronic kidney disease classification in HIV-infected Japanese patients

S. Higasa, Megumi Yasuda, Shinichi Hikasa, 2017, Clinical and Experimental Nephrology.

A potential drug interaction between phenobarbital and dolutegravir: A case report.

S. Higasa, Shinichi Hikasa, Shota Shimabukuro, 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A.

K. Yoneyama, K. Nogami, K. Amano, 2022, Journal of thrombosis and haemostasis : JTH.

Bleeding complication with essential thrombocythemia

S. Higasa, Tazuko Tokugawa, Masaya Okada, 2021, Japanese Journal of Thrombosis and Hemostasis.

Alterations of Guidelines for Antiretroviral Therapy in Patients with HIV Infection

S. Higasa, 2004 .